Arsanis, Inc. Announces Formation of Scientific Advisory Board
9/15/2011 10:29:08 AM
VIENNA--(BUSINESS WIRE)--Arsanis, Inc., a biotechnology company dedicated to the development of anti-infective monoclonal antibodies, today announced the establishment of its Scientific Advisory Board to include six internationally recognized opinion leaders in the areas of infectious diseases and monoclonal antibody engineering.
comments powered by